speb/financial-data huggingface dataset:
TMG.V balance_sheet (quarterly, 2026-02-28) — Current Capital Lease Obligation: 293955.00
TMG.V balance_sheet (quarterly, 2026-02-28) — Current Debt: 6486.00
TMG.V balance_sheet (quarterly, 2026-02-28) — Current Debt And Capital Lease Obligation: 300441.00
TMG.V balance_sheet (quarterly, 2026-02-28) — Current Deferred Liabilities: 2863508.00
TMG.V balance_sheet (quarterly, 2026-02-28) — Current Deferred Revenue: 2863508.00
TMG.V balance_sheet (quarterly, 2026-02-28) — Current Liabilities: 7849059.00
TMG.V balance_sheet (quarterly, 2026-02-28) — Current Provisions: 343944.00
TMG.V cash_flow (quarterly, 2026-02-28) — Deferred Income Tax: 10951.00
TMG.V cash_flow (quarterly, 2026-02-28) — Deferred Tax: 10951.00
TMG.V cash_flow (quarterly, 2026-02-28) — Depreciation: 141233.00
TMG.V cash_flow (quarterly, 2026-02-28) — Depreciation Amortization Depletion: 151355.00
TMG.V income_statement (quarterly, 2026-02-28) — Depreciation Amortization Depletion Income Statement: 151355.00
TMG.V cash_flow (quarterly, 2026-02-28) — Depreciation And Amortization: 151355.00
TMG.V income_statement (quarterly, 2026-02-28) — Depreciation And Amortization In Income Statement: 151355.00
TMG.V income_statement (quarterly, 2026-02-28) — Depreciation Income Statement: 141233.00
TMG.V income_statement (quarterly, 2026-02-28) — Diluted Average Shares: 161313500.00
TMG.V income_statement (quarterly, 2026-02-28) — Diluted EPS: 0.00
TMG.V income_statement (quarterly, 2026-02-28) — Diluted NI Availto Com Stockholders: 322627.00
TMG.V income_statement (quarterly, 2026-02-28) — EBIT: 380717.00
TMG.V income_statement (quarterly, 2026-02-28) — EBITDA: 532072.00
TMG.V cash_flow (quarterly, 2026-02-28) — Effect Of Exchange Rate Changes: -36177.00
TMG.V cash_flow (quarterly, 2026-02-28) — End Cash Position: 3956688.00
TMG.V cash_flow (quarterly, 2026-02-28) — Financing Cash Flow: -155389.00
TMG.V cash_flow (quarterly, 2026-02-28) — Free Cash Flow: 2142593.00
TMG.V cash_flow (quarterly, 2026-02-28) — Gain Loss On Sale Of PPE: 187.00
TMG.V income_statement (quarterly, 2026-02-28) — Gain On Sale Of Security: -214120.00
TMG.V balance_sheet (quarterly, 2026-02-28) — Gains Losses Not Affecting Retained Earnings: 525802.00
TMG.V income_statement (quarterly, 2026-02-28) — General And Administrative Expense: 1421989.00
TMG.V balance_sheet (quarterly, 2026-02-28) — Goodwill And Other Intangible Assets: 449547.00
TMG.V balance_sheet (quarterly, 2026-02-28) — Gross Accounts Receivable: 4284451.00
TMG.V balance_sheet (quarterly, 2026-02-28) — Gross PPE: 1304269.00
TMG.V income_statement (quarterly, 2026-02-28) — Gross Profit: 3499980.00
TMG.V income_statement (quarterly, 2026-02-28) — Interest Expense: 29190.00
TMG.V income_statement (quarterly, 2026-02-28) — Interest Expense Non Operating: 29190.00
TMG.V income_statement (quarterly, 2026-02-28) — Interest Income: 6088.00
TMG.V income_statement (quarterly, 2026-02-28) — Interest Income Non Operating: 6088.00
TMG.V cash_flow (quarterly, 2026-02-28) — Interest Paid Cfo: -30512.00
TMG.V cash_flow (quarterly, 2026-02-28) — Interest Received Cfo: 6088.00
TMG.V balance_sheet (quarterly, 2026-02-28) — Inventory: 1942585.00
TMG.V balance_sheet (quarterly, 2026-02-28) — Invested Capital: 4873751.00
TMG.V cash_flow (quarterly, 2026-02-28) — Investing Cash Flow: -346918.00
TMG.V balance_sheet (quarterly, 2026-02-28) — Long Term Capital Lease Obligation: 749249.00
TMG.V balance_sheet (quarterly, 2026-02-28) — Long Term Debt And Capital Lease Obligation: 749249.00
TMG.V cash_flow (quarterly, 2026-02-28) — Long Term Debt Payments: -155389.00
TMG.V balance_sheet (quarterly, 2026-02-28) — Machinery Furniture Equipment: 58649.00
TMG.V balance_sheet (quarterly, 2026-02-28) — Minority Interest: 6962.00
TMG.V income_statement (quarterly, 2026-02-28) — Minority Interests: -14949.00
TMG.V cash_flow (quarterly, 2026-02-28) — Net Common Stock Issuance: 0.00
TMG.V cash_flow (quarterly, 2026-02-28) — Net Foreign Currency Exchange Gain Loss: 85456.00
TMG.V income_statement (quarterly, 2026-02-28) — Net Income: 322627.00
TMG.V income_statement (quarterly, 2026-02-28) — Net Income Common Stockholders: 322627.00
TMG.V income_statement (quarterly, 2026-02-28) — Net Income Continuous Operations: 337576.00
TMG.V income_statement (quarterly, 2026-02-28) — Net Income From Continuing And Discontinued Operation: 322627.00
TMG.V income_statement (quarterly, 2026-02-28) — Net Income From Continuing Operation Net Minority Interest: 322627.00
TMG.V cash_flow (quarterly, 2026-02-28) — Net Income From Continuing Operations: 337576.00
TMG.V income_statement (quarterly, 2026-02-28) — Net Income Including Noncontrolling Interests: 337576.00
TMG.V income_statement (quarterly, 2026-02-28) — Net Interest Income: -24294.00
TMG.V cash_flow (quarterly, 2026-02-28) — Net Issuance Payments Of Debt: -155389.00
TMG.V cash_flow (quarterly, 2026-02-28) — Net Long Term Debt Issuance: -155389.00
TMG.V income_statement (quarterly, 2026-02-28) — Net Non Operating Interest Income Expense: -24294.00
TMG.V balance_sheet (quarterly, 2026-02-28) — Net PPE: 1304269.00
TMG.V cash_flow (quarterly, 2026-02-28) — Net PPE Purchase And Sale: -346918.00
TMG.V balance_sheet (quarterly, 2026-02-28) — Net Tangible Assets: 4417718.00
TMG.V balance_sheet (quarterly, 2026-02-28) — Non Current Deferred Assets: 216304.00
TMG.V balance_sheet (quarterly, 2026-02-28) — Non Current Deferred Liabilities: 942.00
TMG.V balance_sheet (quarterly, 2026-02-28) — Non Current Deferred Taxes Assets: 216304.00
TMG.V balance_sheet (quarterly, 2026-02-28) — Non Current Deferred Taxes Liabilities: 942.00
TMG.V income_statement (quarterly, 2026-02-28) — Normalized EBITDA: 746192.00
TMG.V income_statement (quarterly, 2026-02-28) — Normalized Income: 528249.25
TMG.V cash_flow (quarterly, 2026-02-28) — Operating Cash Flow: 2489511.00
TMG.V cash_flow (quarterly, 2026-02-28) — Operating Gains Losses: 85643.00
TMG.V income_statement (quarterly, 2026-02-28) — Operating Income: 589941.00
TMG.V income_statement (quarterly, 2026-02-28) — Operating Revenue: 9423521.00
TMG.V balance_sheet (quarterly, 2026-02-28) — Ordinary Shares Number: 170962990.00
TMG.V balance_sheet (quarterly, 2026-02-28) — Other Current Borrowings: 6486.00
TMG.V income_statement (quarterly, 2026-02-28) — Other Gand A: 1421989.00
TMG.V income_statement (quarterly, 2026-02-28) — Other Income Expense: -214120.00
TMG.V cash_flow (quarterly, 2026-02-28) — Other Non Cash Items: 24294.00
TMG.V balance_sheet (quarterly, 2026-02-28) — Other Payable: 259719.00
TMG.V balance_sheet (quarterly, 2026-02-28) — Other Properties: 592788.00
TMG.V balance_sheet (quarterly, 2026-02-28) — Other Receivables: 616110.00
TMG.V balance_sheet (quarterly, 2026-02-28) — Payables: 1932261.00
TMG.V balance_sheet (quarterly, 2026-02-28) — Payables And Accrued Expenses: 4137133.00
TMG.V balance_sheet (quarterly, 2026-02-28) — Pensionand Other Post Retirement Benefit Plans Current: 204033.00
TMG.V balance_sheet (quarterly, 2026-02-28) — Prepaid Assets: 456345.00
TMG.V income_statement (quarterly, 2026-02-28) — Pretax Income: 351527.00
TMG.V cash_flow (quarterly, 2026-02-28) — Proceeds From Stock Option Exercised: 0.00
TMG.V balance_sheet (quarterly, 2026-02-28) — Properties: 0.00
TMG.V cash_flow (quarterly, 2026-02-28) — Purchase Of PPE: -346918.00
TMG.V balance_sheet (quarterly, 2026-02-28) — Receivables: 5147739.00
TMG.V income_statement (quarterly, 2026-02-28) — Reconciled Cost Of Revenue: 5923541.00
TMG.V income_statement (quarterly, 2026-02-28) — Reconciled Depreciation: 151355.00
TMG.V cash_flow (quarterly, 2026-02-28) — Repayment Of Debt: -155389.00
TMG.V cash_flow (quarterly, 2026-02-28) — Repurchase Of Capital Stock: 0.00
TMG.V income_statement (quarterly, 2026-02-28) — Research And Development: 58843.00
TMG.V balance_sheet (quarterly, 2026-02-28) — Retained Earnings: -33612967.00
TMG.V income_statement (quarterly, 2026-02-28) — Selling And Marketing Expense: 1277852.00
TMG.V income_statement (quarterly, 2026-02-28) — Selling General And Administration: 2699841.00
TMG.V balance_sheet (quarterly, 2026-02-28) — Share Issued: 170962990.00
TMG.V cash_flow (quarterly, 2026-02-28) — Stock Based Compensation: 68407.00
TMG.V balance_sheet (quarterly, 2026-02-28) — Stockholders Equity: 4867265.00
TMG.V balance_sheet (quarterly, 2026-02-28) — Tangible Book Value: 4417718.00
TMG.V income_statement (quarterly, 2026-02-28) — Tax Effect Of Unusual Items: -8497.75
TMG.V income_statement (quarterly, 2026-02-28) — Tax Provision: 13951.00
TMG.V income_statement (quarterly, 2026-02-28) — Tax Rate For Calcs: 0.04
TMG.V balance_sheet (quarterly, 2026-02-28) — Taxes Receivable: 251559.00
TMG.V cash_flow (quarterly, 2026-02-28) — Taxes Refund Paid: -82634.00
TMG.V balance_sheet (quarterly, 2026-02-28) — Total Assets: 13473477.00
TMG.V balance_sheet (quarterly, 2026-02-28) — Total Capitalization: 4867265.00
TMG.V balance_sheet (quarterly, 2026-02-28) — Total Debt: 1049690.00
TMG.V balance_sheet (quarterly, 2026-02-28) — Total Equity Gross Minority Interest: 4874227.00
TMG.V income_statement (quarterly, 2026-02-28) — Total Expenses: 8833580.00
TMG.V balance_sheet (quarterly, 2026-02-28) — Total Liabilities Net Minority Interest: 8599250.00
TMG.V balance_sheet (quarterly, 2026-02-28) — Total Non Current Assets: 1970120.00
TMG.V balance_sheet (quarterly, 2026-02-28) — Total Non Current Liabilities Net Minority Interest: 750191.00
TMG.V income_statement (quarterly, 2026-02-28) — Total Operating Income As Reported: 375821.00
TMG.V income_statement (quarterly, 2026-02-28) — Total Other Finance Cost: 1192.00
TMG.V balance_sheet (quarterly, 2026-02-28) — Total Tax Payable: 68848.00
TMG.V income_statement (quarterly, 2026-02-28) — Total Unusual Items: -214120.00
TMG.V income_statement (quarterly, 2026-02-28) — Total Unusual Items Excluding Goodwill: -214120.00
TMG.V balance_sheet (quarterly, 2026-02-28) — Working Capital: 3654298.00
TMHC cash_flow (annual, 2021-12-31) — Change In Other Current Assets: -511220000.00
TMHC balance_sheet (annual, 2021-12-31) — Current Debt: 31529000.00
TMHC balance_sheet (annual, 2021-12-31) — Current Debt And Capital Lease Obligation: 31529000.00
TMHC balance_sheet (annual, 2021-12-31) — Financial Assets: 2110000.00
TMHC cash_flow (annual, 2021-12-31) — Gain Loss On Sale Of PPE: 0.00
TMHC income_statement (annual, 2021-12-31) — Interest Expense: 3792000.00
TMHC income_statement (annual, 2021-12-31) — Interest Expense Non Operating: 3792000.00
TMHC balance_sheet (annual, 2021-12-31) — Investmentsin Joint Venturesat Cost: 171406000.00
TMHC cash_flow (annual, 2021-12-31) — Net Other Financing Charges: -59135000.00
TMHC cash_flow (annual, 2021-12-31) — Other Non Cash Items: 38864000.00
TMHC income_statement (annual, 2021-12-31) — Restructuring And Mergern Acquisition: 0.00
TMHC balance_sheet (annual, 2021-12-31) — Total Equity Gross Minority Interest: 3970982000.00
TMHC balance_sheet (annual, 2021-12-31) — Treasury Shares Number: 36828559.00
TMHC income_statement (annual, 2022-12-31) — +Operating Expense: 643212000.00
TMHC income_statement (annual, 2022-12-31) — +Total Revenue: 8224917000.00
TMHC balance_sheet (annual, 2022-12-31) — Accounts Payable: 269761000.00
TMHC balance_sheet (annual, 2022-12-31) — Additional Paid In Capital: 3025489000.00
TMHC cash_flow (annual, 2022-12-31) — Asset Impairment Charge: 24870000.00
TMHC balance_sheet (annual, 2022-12-31) — Assets Held For Sale Current: 346364000.00
TMHC income_statement (annual, 2022-12-31) — Basic Average Shares: 114982000.00
TMHC income_statement (annual, 2022-12-31) — Basic EPS: 9.16
TMHC cash_flow (annual, 2022-12-31) — Beginning Cash Position: 836340000.00
TMHC cash_flow (annual, 2022-12-31) — Capital Expenditure: -30581000.00
TMHC balance_sheet (annual, 2022-12-31) — Capital Lease Obligations: 100174000.00
TMHC balance_sheet (annual, 2022-12-31) — Capital Stock: 1000.00
TMHC balance_sheet (annual, 2022-12-31) — Cash And Cash Equivalents: 724488000.00
TMHC balance_sheet (annual, 2022-12-31) — Cash Cash Equivalents And Short Term Investments: 724488000.00
TMHC cash_flow (annual, 2022-12-31) — Cash Flow From Continuing Financing Activities: -1202597000.00
TMHC cash_flow (annual, 2022-12-31) — Cash Flow From Continuing Investing Activities: -14880000.00
TMHC cash_flow (annual, 2022-12-31) — Cash Flow From Continuing Operating Activities: 1107772000.00
TMHC cash_flow (annual, 2022-12-31) — Change In Account Payable: -61849000.00
TMHC cash_flow (annual, 2022-12-31) — Change In Income Tax Payable: 0.00
TMHC cash_flow (annual, 2022-12-31) — Change In Inventory: -50792000.00
TMHC cash_flow (annual, 2022-12-31) — Change In Other Current Assets: 5789000.00
TMHC cash_flow (annual, 2022-12-31) — Change In Other Working Capital: -73613000.00
TMHC cash_flow (annual, 2022-12-31) — Change In Payable: -61849000.00
TMHC cash_flow (annual, 2022-12-31) — Change In Payables And Accrued Expense: -61849000.00
TMHC cash_flow (annual, 2022-12-31) — Change In Receivables: 5789000.00
TMHC cash_flow (annual, 2022-12-31) — Change In Tax Payable: 0.00
TMHC cash_flow (annual, 2022-12-31) — Change In Working Capital: -180465000.00
TMHC cash_flow (annual, 2022-12-31) — Changes In Cash: -109705000.00
TMHC balance_sheet (annual, 2022-12-31) — Common Stock: 1000.00
TMHC balance_sheet (annual, 2022-12-31) — Common Stock Equity: 4630326000.00
TMHC cash_flow (annual, 2022-12-31) — Common Stock Payments: -376275000.00
TMHC balance_sheet (annual, 2022-12-31) — Construction In Progress: 263356000.00
TMHC income_statement (annual, 2022-12-31) — Cost Of Revenue: 6132551000.00
TMHC balance_sheet (annual, 2022-12-31) — Current Accrued Expenses: 186238000.00
TMHC balance_sheet (annual, 2022-12-31) — Current Assets: 6900771000.00
TMHC balance_sheet (annual, 2022-12-31) — Current Deferred Liabilities: 412092000.00
TMHC balance_sheet (annual, 2022-12-31) — Current Deferred Revenue: 412092000.00
TMHC balance_sheet (annual, 2022-12-31) — Current Liabilities: 898137000.00
TMHC cash_flow (annual, 2022-12-31) — Deferred Income Tax: 83584000.00
TMHC cash_flow (annual, 2022-12-31) — Deferred Tax: 83584000.00
TMHC cash_flow (annual, 2022-12-31) — Depreciation Amortization Depletion: 33839000.00
TMHC cash_flow (annual, 2022-12-31) — Depreciation And Amortization: 33839000.00
TMHC income_statement (annual, 2022-12-31) — Diluted Average Shares: 116221000.00
TMHC income_statement (annual, 2022-12-31) — Diluted EPS: 9.06
TMHC income_statement (annual, 2022-12-31) — Diluted NI Availto Com Stockholders: 1052800000.00
TMHC cash_flow (annual, 2022-12-31) — Dividend Received Cfo: 5270000.00
TMHC cash_flow (annual, 2022-12-31) — Dividends Received Cfi: 125275000.00
TMHC income_statement (annual, 2022-12-31) — EBIT: 1449154000.00
TMHC income_statement (annual, 2022-12-31) — EBITDA: 1482993000.00
TMHC income_statement (annual, 2022-12-31) — Earnings From Equity Interest: -14184000.00
TMHC cash_flow (annual, 2022-12-31) — Earnings Losses From Equity Investments: 14184000.00
TMHC balance_sheet (annual, 2022-12-31) — Employee Benefits: 112294000.00
TMHC cash_flow (annual, 2022-12-31) — End Cash Position: 726635000.00
TMHC balance_sheet (annual, 2022-12-31) — Financial Assets: 1090000.00
TMHC cash_flow (annual, 2022-12-31) — Financing Cash Flow: -1202597000.00
TMHC balance_sheet (annual, 2022-12-31) — Finished Goods: 5370876000.00
TMHC cash_flow (annual, 2022-12-31) — Free Cash Flow: 1077191000.00
TMHC cash_flow (annual, 2022-12-31) — Gain Loss On Sale Of PPE: -14508000.00
TMHC balance_sheet (annual, 2022-12-31) — Gains Losses Not Affecting Retained Earnings: 359000.00
TMHC income_statement (annual, 2022-12-31) — General And Administrative Expense: 245138000.00
TMHC balance_sheet (annual, 2022-12-31) — Goodwill: 663197000.00
TMHC balance_sheet (annual, 2022-12-31) — Goodwill And Other Intangible Assets: 663197000.00
TMHC balance_sheet (annual, 2022-12-31) — Gross PPE: 556200000.00
TMHC income_statement (annual, 2022-12-31) — Gross Profit: 2092366000.00
TMHC cash_flow (annual, 2022-12-31) — Income Tax Paid Supplemental Data: 270034000.00
TMHC income_statement (annual, 2022-12-31) — Interest Expense: 17674000.00
TMHC income_statement (annual, 2022-12-31) — Interest Expense Non Operating: 17674000.00
TMHC balance_sheet (annual, 2022-12-31) — Interest Payable: 37434000.00
TMHC balance_sheet (annual, 2022-12-31) — Inventory: 5370876000.00
TMHC balance_sheet (annual, 2022-12-31) — Invested Capital: 7114187000.00
TMHC cash_flow (annual, 2022-12-31) — Investing Cash Flow: -14880000.00
TMHC balance_sheet (annual, 2022-12-31) — Investments And Advances: 282900000.00
TMHC balance_sheet (annual, 2022-12-31) — Investmentsin Joint Venturesat Cost: 282900000.00
TMHC cash_flow (annual, 2022-12-31) — Issuance Of Debt: 3081462000.00
TMHC balance_sheet (annual, 2022-12-31) — Line Of Credit: 0.00
TMHC balance_sheet (annual, 2022-12-31) — Long Term Capital Lease Obligation: 100174000.00
TMHC balance_sheet (annual, 2022-12-31) — Long Term Debt: 2483861000.00
TMHC balance_sheet (annual, 2022-12-31) — Long Term Debt And Capital Lease Obligation: 2584035000.00
TMHC cash_flow (annual, 2022-12-31) — Long Term Debt Issuance: 2700443000.00
TMHC cash_flow (annual, 2022-12-31) — Long Term Debt Payments: -3465352000.00
TMHC balance_sheet (annual, 2022-12-31) — Long Term Equity Investment: 282900000.00
TMHC balance_sheet (annual, 2022-12-31) — Long Term Provisions: 161675000.00
TMHC balance_sheet (annual, 2022-12-31) — Minority Interest: 16533000.00
TMHC income_statement (annual, 2022-12-31) — Minority Interests: -3447000.00
TMHC cash_flow (annual, 2022-12-31) — Net Business Purchase And Sale: -109574000.00
TMHC cash_flow (annual, 2022-12-31) — Net Common Stock Issuance: -376275000.00
TMHC balance_sheet (annual, 2022-12-31) — Net Debt: 1759373000.00
TMHC income_statement (annual, 2022-12-31) — Net Income: 1052800000.00
TMHC income_statement (annual, 2022-12-31) — Net Income Common Stockholders: 1052800000.00
TMHC income_statement (annual, 2022-12-31) — Net Income Continuous Operations: 1056247000.00
TMHC income_statement (annual, 2022-12-31) — Net Income From Continuing And Discontinued Operation: 1052800000.00
TMHC income_statement (annual, 2022-12-31) — Net Income From Continuing Operation Net Minority Interest: 1052800000.00
TMHC cash_flow (annual, 2022-12-31) — Net Income From Continuing Operations: 1056247000.00
TMHC income_statement (annual, 2022-12-31) — Net Income Including Noncontrolling Interests: 1056247000.00
TMHC income_statement (annual, 2022-12-31) — Net Interest Income: -17674000.00
TMHC cash_flow (annual, 2022-12-31) — Net Investment Purchase And Sale: 0.00
TMHC cash_flow (annual, 2022-12-31) — Net Issuance Payments Of Debt: -796438000.00
TMHC cash_flow (annual, 2022-12-31) — Net Long Term Debt Issuance: -764909000.00
TMHC income_statement (annual, 2022-12-31) — Net Non Operating Interest Income Expense: -17674000.00
TMHC cash_flow (annual, 2022-12-31) — Net Other Financing Charges: -31261000.00
TMHC balance_sheet (annual, 2022-12-31) — Net PPE: 556200000.00
TMHC cash_flow (annual, 2022-12-31) — Net PPE Purchase And Sale: -30581000.00
TMHC cash_flow (annual, 2022-12-31) — Net Short Term Debt Issuance: -31529000.00
TMHC balance_sheet (annual, 2022-12-31) — Net Tangible Assets: 3967129000.00
TMHC balance_sheet (annual, 2022-12-31) — Non Current Deferred Assets: 67656000.00
TMHC balance_sheet (annual, 2022-12-31) — Non Current Deferred Taxes Assets: 67656000.00
TMHC income_statement (annual, 2022-12-31) — Normalized EBITDA: 1469117000.00
TMHC income_statement (annual, 2022-12-31) — Normalized Income: 1042281992.00
TMHC cash_flow (annual, 2022-12-31) — Operating Cash Flow: 1107772000.00
TMHC cash_flow (annual, 2022-12-31) — Operating Gains Losses: -14200000.00
TMHC income_statement (annual, 2022-12-31) — Operating Income: 1449154000.00
TMHC income_statement (annual, 2022-12-31) — Operating Revenue: 8224917000.00
TMHC balance_sheet (annual, 2022-12-31) — Ordinary Shares Number: 107995262.00
TMHC balance_sheet (annual, 2022-12-31) — Other Current Assets: 219520000.00
TMHC balance_sheet (annual, 2022-12-31) — Other Equity Adjustments: 359000.00
TMHC income_statement (annual, 2022-12-31) — Other Gand A: 245138000.00
TMHC income_statement (annual, 2022-12-31) — Other Income Expense: -38805000.00
TMHC cash_flow (annual, 2022-12-31) — Other Non Cash Items: 71726000.00
TMHC balance_sheet (annual, 2022-12-31) — Other Non Current Liabilities: 67724000.00
TMHC income_statement (annual, 2022-12-31) — Other Non Operating Income Expenses: -38497000.00
TMHC balance_sheet (annual, 2022-12-31) — Other Properties: 292844000.00
TMHC balance_sheet (annual, 2022-12-31) — Other Receivables: 191504000.00
TMHC income_statement (annual, 2022-12-31) — Other Special Charges: -13876000.00
TMHC balance_sheet (annual, 2022-12-31) — Payables: 299807000.00
TMHC balance_sheet (annual, 2022-12-31) — Payables And Accrued Expenses: 486045000.00
TMHC balance_sheet (annual, 2022-12-31) — Prepaid Assets: 45872000.00
TMHC income_statement (annual, 2022-12-31) — Pretax Income: 1392675000.00
TMHC cash_flow (annual, 2022-12-31) — Proceeds From Stock Option Exercised: 1377000.00
TMHC cash_flow (annual, 2022-12-31) — Purchase Of Business: -109574000.00
TMHC cash_flow (annual, 2022-12-31) — Purchase Of Investment: 0.00
TMHC cash_flow (annual, 2022-12-31) — Purchase Of PPE: -30581000.00
TMHC balance_sheet (annual, 2022-12-31) — Receivables: 191504000.00
TMHC income_statement (annual, 2022-12-31) — Reconciled Cost Of Revenue: 6132551000.00
TMHC income_statement (annual, 2022-12-31) — Reconciled Depreciation: 33839000.00
TMHC cash_flow (annual, 2022-12-31) — Repayment Of Debt: -3877900000.00
TMHC cash_flow (annual, 2022-12-31) — Repurchase Of Capital Stock: -376275000.00
TMHC balance_sheet (annual, 2022-12-31) — Restricted Cash: 2147000.00
TMHC income_statement (annual, 2022-12-31) — Restructuring And Mergern Acquisition: 0.00
TMHC balance_sheet (annual, 2022-12-31) — Retained Earnings: 2741615000.00
TMHC income_statement (annual, 2022-12-31) — Selling And Marketing Expense: 398074000.00
TMHC income_statement (annual, 2022-12-31) — Selling General And Administration: 643212000.00
TMHC balance_sheet (annual, 2022-12-31) — Share Issued: 159392185.00
TMHC cash_flow (annual, 2022-12-31) — Short Term Debt Issuance: 381019000.00
TMHC cash_flow (annual, 2022-12-31) — Short Term Debt Payments: -412548000.00
TMHC income_statement (annual, 2022-12-31) — Special Income Charges: 13876000.00
TMHC cash_flow (annual, 2022-12-31) — Stock Based Compensation: 26901000.00
TMHC balance_sheet (annual, 2022-12-31) — Stockholders Equity: 4630326000.00
TMHC balance_sheet (annual, 2022-12-31) — Tangible Book Value: 3967129000.00
TMHC income_statement (annual, 2022-12-31) — Tax Effect Of Unusual Items: 3357992.00
TMHC income_statement (annual, 2022-12-31) — Tax Provision: 336428000.00
TMHC income_statement (annual, 2022-12-31) — Tax Rate For Calcs: 0.24
TMHC balance_sheet (annual, 2022-12-31) — Total Assets: 8470724000.00
TMHC balance_sheet (annual, 2022-12-31) — Total Capitalization: 7114187000.00
TMHC balance_sheet (annual, 2022-12-31) — Total Debt: 2584035000.00
TMHC balance_sheet (annual, 2022-12-31) — Total Equity Gross Minority Interest: 4646859000.00
TMHC income_statement (annual, 2022-12-31) — Total Expenses: 6775763000.00
TMHC balance_sheet (annual, 2022-12-31) — Total Liabilities Net Minority Interest: 3823865000.00
TMHC balance_sheet (annual, 2022-12-31) — Total Non Current Assets: 1569953000.00
TMHC balance_sheet (annual, 2022-12-31) — Total Non Current Liabilities Net Minority Interest: 2925728000.00
TMHC income_statement (annual, 2022-12-31) — Total Other Finance Cost: 17674000.00
TMHC balance_sheet (annual, 2022-12-31) — Total Tax Payable: 30046000.00
TMHC income_statement (annual, 2022-12-31) — Total Unusual Items: 13876000.00
TMHC income_statement (annual, 2022-12-31) — Total Unusual Items Excluding Goodwill: 13876000.00
TMHC balance_sheet (annual, 2022-12-31) — Treasury Shares Number: 51396923.00
TMHC balance_sheet (annual, 2022-12-31) — Treasury Stock: 1137138000.00
TMHC balance_sheet (annual, 2022-12-31) — Working Capital: 6002634000.00
TMHC income_statement (annual, 2023-12-31) — +Operating Expense: 698707000.00
TMHC income_statement (annual, 2023-12-31) — +Total Revenue: 7417831000.00
TMHC balance_sheet (annual, 2023-12-31) — Accounts Payable: 263481000.00
TMHC balance_sheet (annual, 2023-12-31) — Additional Paid In Capital: 3068597000.00
TMHC cash_flow (annual, 2023-12-31) — Asset Impairment Charge: 11791000.00
TMHC balance_sheet (annual, 2023-12-31) — Assets Held For Sale Current: 193344000.00
TMHC income_statement (annual, 2023-12-31) — Basic Average Shares: 108424000.00
TMHC income_statement (annual, 2023-12-31) — Basic EPS: 7.09
TMHC cash_flow (annual, 2023-12-31) — Beginning Cash Position: 726635000.00
TMHC cash_flow (annual, 2023-12-31) — Capital Expenditure: -33426000.00
TMHC balance_sheet (annual, 2023-12-31) — Capital Lease Obligations: 84999000.00
TMHC balance_sheet (annual, 2023-12-31) — Capital Stock: 1000.00
TMHC balance_sheet (annual, 2023-12-31) — Cash And Cash Equivalents: 798568000.00
TMHC balance_sheet (annual, 2023-12-31) — Cash Cash Equivalents And Short Term Investments: 798568000.00
TMHC cash_flow (annual, 2023-12-31) — Cash Flow From Continuing Financing Activities: -628514000.00
TMHC cash_flow (annual, 2023-12-31) — Cash Flow From Continuing Investing Activities: -97191000.00
TMHC cash_flow (annual, 2023-12-31) — Cash Flow From Continuing Operating Activities: 806169000.00
TMHC cash_flow (annual, 2023-12-31) — Change In Account Payable: 84811000.00
TMHC cash_flow (annual, 2023-12-31) — Change In Income Tax Payable: 0.00
TMHC cash_flow (annual, 2023-12-31) — Change In Inventory: -78575000.00
TMHC cash_flow (annual, 2023-12-31) — Change In Other Working Capital: -86005000.00
TMHC cash_flow (annual, 2023-12-31) — Change In Payable: 84811000.00
TMHC cash_flow (annual, 2023-12-31) — Change In Payables And Accrued Expense: 84811000.00
TMHC cash_flow (annual, 2023-12-31) — Change In Receivables: 31012000.00
TMHC cash_flow (annual, 2023-12-31) — Change In Tax Payable: 0.00
TMHC cash_flow (annual, 2023-12-31) — Change In Working Capital: -48757000.00
TMHC cash_flow (annual, 2023-12-31) — Changes In Cash: 80464000.00
TMHC balance_sheet (annual, 2023-12-31) — Common Stock: 1000.00
TMHC balance_sheet (annual, 2023-12-31) — Common Stock Equity: 5314941000.00
TMHC cash_flow (annual, 2023-12-31) — Common Stock Payments: -127959000.00
TMHC balance_sheet (annual, 2023-12-31) — Construction In Progress: 203217000.00
TMHC income_statement (annual, 2023-12-31) — Cost Of Revenue: 5634758000.00
TMHC balance_sheet (annual, 2023-12-31) — Current Accrued Expenses: 184644000.00
TMHC balance_sheet (annual, 2023-12-31) — Current Assets: 7021332000.00
TMHC balance_sheet (annual, 2023-12-31) — Current Deferred Liabilities: 326087000.00
TMHC balance_sheet (annual, 2023-12-31) — Current Deferred Revenue: 326087000.00
TMHC balance_sheet (annual, 2023-12-31) — Current Liabilities: 805099000.00
TMHC cash_flow (annual, 2023-12-31) — Deferred Income Tax: -169000.00
TMHC cash_flow (annual, 2023-12-31) — Deferred Tax: -169000.00
TMHC cash_flow (annual, 2023-12-31) — Depreciation Amortization Depletion: 33406000.00
TMHC cash_flow (annual, 2023-12-31) — Depreciation And Amortization: 33406000.00
TMHC income_statement (annual, 2023-12-31) — Diluted Average Shares: 110145000.00
TMHC income_statement (annual, 2023-12-31) — Diluted EPS: 6.98
TMHC income_statement (annual, 2023-12-31) — Diluted NI Availto Com Stockholders: 768929000.00
TMHC cash_flow (annual, 2023-12-31) — Dividend Received Cfo: 9230000.00
TMHC cash_flow (annual, 2023-12-31) — Dividends Received Cfi: 824000.00
TMHC income_statement (annual, 2023-12-31) — EBIT: 1084366000.00
TMHC income_statement (annual, 2023-12-31) — EBITDA: 1117772000.00
TMHC income_statement (annual, 2023-12-31) — Earnings From Equity Interest: 8757000.00
TMHC cash_flow (annual, 2023-12-31) — Earnings Losses From Equity Investments: -8757000.00
TMHC balance_sheet (annual, 2023-12-31) — Employee Benefits: 149095000.00
TMHC cash_flow (annual, 2023-12-31) — End Cash Position: 807099000.00
TMHC cash_flow (annual, 2023-12-31) — Financing Cash Flow: -628514000.00
TMHC balance_sheet (annual, 2023-12-31) — Finished Goods: 5545446000.00
TMHC cash_flow (annual, 2023-12-31) — Free Cash Flow: 772743000.00
TMHC cash_flow (annual, 2023-12-31) — Gain Loss On Sale Of PPE: 0.00
TMHC balance_sheet (annual, 2023-12-31) — Gains Losses Not Affecting Retained Earnings: 896000.00
TMHC income_statement (annual, 2023-12-31) — General And Administrative Expense: 280573000.00
TMHC balance_sheet (annual, 2023-12-31) — Goodwill: 663197000.00
TMHC balance_sheet (annual, 2023-12-31) — Goodwill And Other Intangible Assets: 663197000.00
TMHC balance_sheet (annual, 2023-12-31) — Gross PPE: 573541000.00
TMHC income_statement (annual, 2023-12-31) — Gross Profit: 1783073000.00
TMHC cash_flow (annual, 2023-12-31) — Income Tax Paid Supplemental Data: 204274000.00
TMHC balance_sheet (annual, 2023-12-31) — Income Tax Payable: 0.00
TMHC balance_sheet (annual, 2023-12-31) — Interest Payable: 31042000.00
TMHC balance_sheet (annual, 2023-12-31) — Inventory: 5545446000.00
TMHC balance_sheet (annual, 2023-12-31) — Invested Capital: 7332043000.00
TMHC cash_flow (annual, 2023-12-31) — Investing Cash Flow: -97191000.00
TMHC balance_sheet (annual, 2023-12-31) — Investments And Advances: 346192000.00
TMHC balance_sheet (annual, 2023-12-31) — Investmentsin Joint Venturesat Cost: 346192000.00
TMHC cash_flow (annual, 2023-12-31) — Issuance Of Debt: 3014785000.00
TMHC balance_sheet (annual, 2023-12-31) — Line Of Credit: 0.00
TMHC balance_sheet (annual, 2023-12-31) — Long Term Capital Lease Obligation: 84999000.00
TMHC balance_sheet (annual, 2023-12-31) — Long Term Debt: 2017102000.00
TMHC balance_sheet (annual, 2023-12-31) — Long Term Debt And Capital Lease Obligation: 2102101000.00
TMHC cash_flow (annual, 2023-12-31) — Long Term Debt Issuance: 3014785000.00
TMHC cash_flow (annual, 2023-12-31) — Long Term Debt Payments: -3532353000.00
TMHC balance_sheet (annual, 2023-12-31) — Long Term Equity Investment: 346192000.00
TMHC balance_sheet (annual, 2023-12-31) — Long Term Provisions: 184448000.00
TMHC balance_sheet (annual, 2023-12-31) — Minority Interest: 17345000.00
TMHC income_statement (annual, 2023-12-31) — Minority Interests: -812000.00
TMHC cash_flow (annual, 2023-12-31) — Net Business Purchase And Sale: -64589000.00
TMHC cash_flow (annual, 2023-12-31) — Net Common Stock Issuance: -127959000.00
TMHC balance_sheet (annual, 2023-12-31) — Net Debt: 1218534000.00
TMHC income_statement (annual, 2023-12-31) — Net Income: 768929000.00
TMHC income_statement (annual, 2023-12-31) — Net Income Common Stockholders: 768929000.00
TMHC income_statement (annual, 2023-12-31) — Net Income Continuous Operations: 769741000.00
TMHC income_statement (annual, 2023-12-31) — Net Income From Continuing And Discontinued Operation: 768929000.00
TMHC income_statement (annual, 2023-12-31) — Net Income From Continuing Operation Net Minority Interest: 768929000.00
TMHC cash_flow (annual, 2023-12-31) — Net Income From Continuing Operations: 769741000.00
TMHC income_statement (annual, 2023-12-31) — Net Income Including Noncontrolling Interests: 769741000.00
TMHC income_statement (annual, 2023-12-31) — Net Interest Income: 12577000.00
TMHC cash_flow (annual, 2023-12-31) — Net Investment Purchase And Sale: 0.00
TMHC cash_flow (annual, 2023-12-31) — Net Issuance Payments Of Debt: -517568000.00
TMHC cash_flow (annual, 2023-12-31) — Net Long Term Debt Issuance: -517568000.00
TMHC income_statement (annual, 2023-12-31) — Net Non Operating Interest Income Expense: 12577000.00
TMHC balance_sheet (annual, 2023-12-31) — Net PPE: 573541000.00
TMHC cash_flow (annual, 2023-12-31) — Net PPE Purchase And Sale: -33426000.00
TMHC cash_flow (annual, 2023-12-31) — Net Short Term Debt Issuance: 0.00
TMHC balance_sheet (annual, 2023-12-31) — Net Tangible Assets: 4651744000.00
TMHC balance_sheet (annual, 2023-12-31) — Non Current Deferred Assets: 67825000.00
TMHC balance_sheet (annual, 2023-12-31) — Non Current Deferred Taxes Assets: 67825000.00
TMHC income_statement (annual, 2023-12-31) — Normalized EBITDA: 1118067000.00
TMHC income_statement (annual, 2023-12-31) — Normalized Income: 769152020.00
TMHC cash_flow (annual, 2023-12-31) — Operating Cash Flow: 806169000.00
TMHC cash_flow (annual, 2023-12-31) — Operating Gains Losses: -8462000.00
TMHC income_statement (annual, 2023-12-31) — Operating Income: 1084366000.00
TMHC income_statement (annual, 2023-12-31) — Operating Revenue: 7417831000.00
TMHC balance_sheet (annual, 2023-12-31) — Ordinary Shares Number: 106917636.00
TMHC balance_sheet (annual, 2023-12-31) — Other Current Assets: 249615000.00
TMHC balance_sheet (annual, 2023-12-31) — Other Equity Adjustments: 896000.00
TMHC income_statement (annual, 2023-12-31) — Other Gand A: 280573000.00
TMHC income_statement (annual, 2023-12-31) — Other Income Expense: -79105000.00
TMHC cash_flow (annual, 2023-12-31) — Other Non Cash Items: 13294000.00
TMHC balance_sheet (annual, 2023-12-31) — Other Non Current Liabilities: 99058000.00
TMHC income_statement (annual, 2023-12-31) — Other Non Operating Income Expenses: -87567000.00
TMHC balance_sheet (annual, 2023-12-31) — Other Properties: 370324000.00
TMHC balance_sheet (annual, 2023-12-31) — Other Receivables: 184518000.00
TMHC income_statement (annual, 2023-12-31) — Other Special Charges: 295000.00
TMHC balance_sheet (annual, 2023-12-31) — Payables: 294368000.00
TMHC balance_sheet (annual, 2023-12-31) — Payables And Accrued Expenses: 479012000.00
TMHC balance_sheet (annual, 2023-12-31) — Prepaid Assets: 41310000.00
TMHC income_statement (annual, 2023-12-31) — Pretax Income: 1017838000.00
TMHC cash_flow (annual, 2023-12-31) — Proceeds From Stock Option Exercised: 17013000.00
TMHC cash_flow (annual, 2023-12-31) — Purchase Of Business: -64589000.00
TMHC cash_flow (annual, 2023-12-31) — Purchase Of Investment: 0.00
TMHC cash_flow (annual, 2023-12-31) — Purchase Of PPE: -33426000.00
TMHC balance_sheet (annual, 2023-12-31) — Receivables: 184518000.00
TMHC income_statement (annual, 2023-12-31) — Reconciled Cost Of Revenue: 5634758000.00
TMHC income_statement (annual, 2023-12-31) — Reconciled Depreciation: 33406000.00
TMHC cash_flow (annual, 2023-12-31) — Repayment Of Debt: -3532353000.00
TMHC cash_flow (annual, 2023-12-31) — Repurchase Of Capital Stock: -127959000.00
TMHC balance_sheet (annual, 2023-12-31) — Restricted Cash: 8531000.00
TMHC balance_sheet (annual, 2023-12-31) — Retained Earnings: 3510544000.00
TMHC cash_flow (annual, 2023-12-31) — Sale Of Investment: 0.00
TMHC income_statement (annual, 2023-12-31) — Selling And Marketing Expense: 418134000.00
TMHC income_statement (annual, 2023-12-31) — Selling General And Administration: 698707000.00
TMHC balance_sheet (annual, 2023-12-31) — Share Issued: 161129515.00
TMHC cash_flow (annual, 2023-12-31) — Short Term Debt Issuance: 0.00
TMHC cash_flow (annual, 2023-12-31) — Short Term Debt Payments: 0.00
TMHC income_statement (annual, 2023-12-31) — Special Income Charges: -295000.00
TMHC cash_flow (annual, 2023-12-31) — Stock Based Compensation: 26095000.00
TMHC balance_sheet (annual, 2023-12-31) — Stockholders Equity: 5314941000.00
TMHC balance_sheet (annual, 2023-12-31) — Tangible Book Value: 4651744000.00
TMHC income_statement (annual, 2023-12-31) — Tax Effect Of Unusual Items: -71980.00
TMHC income_statement (annual, 2023-12-31) — Tax Provision: 248097000.00
TMHC income_statement (annual, 2023-12-31) — Tax Rate For Calcs: 0.24
TMHC balance_sheet (annual, 2023-12-31) — Total Assets: 8672087000.00
TMHC balance_sheet (annual, 2023-12-31) — Total Capitalization: 7332043000.00
TMHC balance_sheet (annual, 2023-12-31) — Total Debt: 2102101000.00
TMHC balance_sheet (annual, 2023-12-31) — Total Equity Gross Minority Interest: 5332286000.00
TMHC income_statement (annual, 2023-12-31) — Total Expenses: 6333465000.00
TMHC balance_sheet (annual, 2023-12-31) — Total Liabilities Net Minority Interest: 3339801000.00
TMHC balance_sheet (annual, 2023-12-31) — Total Non Current Assets: 1650755000.00
TMHC balance_sheet (annual, 2023-12-31) — Total Non Current Liabilities Net Minority Interest: 2534702000.00
TMHC income_statement (annual, 2023-12-31) — Total Other Finance Cost: -12577000.00
TMHC balance_sheet (annual, 2023-12-31) — Total Tax Payable: 30887000.00
TMHC income_statement (annual, 2023-12-31) — Total Unusual Items: -295000.00
TMHC income_statement (annual, 2023-12-31) — Total Unusual Items Excluding Goodwill: -295000.00
TMHC balance_sheet (annual, 2023-12-31) — Treasury Shares Number: 54211879.00
TMHC balance_sheet (annual, 2023-12-31) — Treasury Stock: 1265097000.00
TMHC balance_sheet (annual, 2023-12-31) — Working Capital: 6216233000.00
TMHC balance_sheet (quarterly, 2024-09-30) — Other Non Current Assets: 336051000.00
TMHC income_statement (quarterly, 2024-09-30) — Special Income Charges: 0.00
TMHC income_statement (quarterly, 2024-09-30) — Total Unusual Items: 0.00
TMHC income_statement (quarterly, 2024-09-30) — Total Unusual Items Excluding Goodwill: 0.00
TMHC income_statement (annual, 2024-12-31) — +Operating Expense: 770498000.00
TMHC income_statement (annual, 2024-12-31) — +Total Revenue: 8168136000.00
TMHC balance_sheet (annual, 2024-12-31) — Accounts Payable: 270266000.00
TMHC balance_sheet (annual, 2024-12-31) — Additional Paid In Capital: 3086342000.00
TMHC cash_flow (annual, 2024-12-31) — Asset Impairment Charge: 29637000.00
TMHC balance_sheet (annual, 2024-12-31) — Assets Held For Sale Current: 207936000.00
TMHC income_statement (annual, 2024-12-31) — Basic Average Shares: 104813000.00
TMHC income_statement (annual, 2024-12-31) — Basic EPS: 8.43
TMHC cash_flow (annual, 2024-12-31) — Beginning Cash Position: 807099000.00
TMHC cash_flow (annual, 2024-12-31) — Capital Expenditure: -36330000.00
TMHC balance_sheet (annual, 2024-12-31) — Capital Lease Obligations: 78998000.00
TMHC balance_sheet (annual, 2024-12-31) — Capital Stock: 1000.00
TMHC balance_sheet (annual, 2024-12-31) — Cash And Cash Equivalents: 487151000.00
TMHC balance_sheet (annual, 2024-12-31) — Cash Cash Equivalents And Short Term Investments: 487151000.00
TMHC cash_flow (annual, 2024-12-31) — Cash Flow From Continuing Financing Activities: -393571000.00
TMHC cash_flow (annual, 2024-12-31) — Cash Flow From Continuing Investing Activities: -136441000.00
TMHC cash_flow (annual, 2024-12-31) — Cash Flow From Continuing Operating Activities: 210079000.00
TMHC cash_flow (annual, 2024-12-31) — Change In Account Payable: 215993000.00
TMHC cash_flow (annual, 2024-12-31) — Change In Income Tax Payable: 2243000.00
TMHC cash_flow (annual, 2024-12-31) — Change In Inventory: -797330000.00
TMHC cash_flow (annual, 2024-12-31) — Change In Other Working Capital: -86936000.00
TMHC cash_flow (annual, 2024-12-31) — Change In Payable: 218236000.00
TMHC cash_flow (annual, 2024-12-31) — Change In Payables And Accrued Expense: 218236000.00
TMHC cash_flow (annual, 2024-12-31) — Change In Receivables: -182084000.00
TMHC cash_flow (annual, 2024-12-31) — Change In Tax Payable: 2243000.00
TMHC cash_flow (annual, 2024-12-31) — Change In Working Capital: -848114000.00
TMHC cash_flow (annual, 2024-12-31) — Changes In Cash: -319933000.00
TMHC balance_sheet (annual, 2024-12-31) — Common Stock: 1000.00
TMHC balance_sheet (annual, 2024-12-31) — Common Stock Equity: 5866535000.00
TMHC cash_flow (annual, 2024-12-31) — Common Stock Payments: -347598000.00
TMHC balance_sheet (annual, 2024-12-31) — Construction In Progress: 299668000.00
TMHC income_statement (annual, 2024-12-31) — Cost Of Revenue: 6183924000.00
TMHC balance_sheet (annual, 2024-12-31) — Current Accrued Expenses: 207061000.00
TMHC balance_sheet (annual, 2024-12-31) — Current Assets: 7517531000.00
TMHC balance_sheet (annual, 2024-12-31) — Current Deferred Liabilities: 239151000.00
TMHC balance_sheet (annual, 2024-12-31) — Current Deferred Revenue: 239151000.00
TMHC balance_sheet (annual, 2024-12-31) — Current Liabilities: 755296000.00
TMHC cash_flow (annual, 2024-12-31) — Deferred Income Tax: -8423000.00
TMHC cash_flow (annual, 2024-12-31) — Deferred Tax: -8423000.00
TMHC cash_flow (annual, 2024-12-31) — Depreciation Amortization Depletion: 41190000.00
TMHC cash_flow (annual, 2024-12-31) — Depreciation And Amortization: 41190000.00
TMHC income_statement (annual, 2024-12-31) — Diluted Average Shares: 106846000.00
TMHC income_statement (annual, 2024-12-31) — Diluted EPS: 8.27
TMHC income_statement (annual, 2024-12-31) — Diluted NI Availto Com Stockholders: 883309000.00
TMHC cash_flow (annual, 2024-12-31) — Dividend Received Cfo: 12929000.00
TMHC cash_flow (annual, 2024-12-31) — Dividends Received Cfi: 29698000.00
TMHC income_statement (annual, 2024-12-31) — EBIT: 1213714000.00
TMHC income_statement (annual, 2024-12-31) — EBITDA: 1254904000.00
TMHC income_statement (annual, 2024-12-31) — Earnings From Equity Interest: 6347000.00
TMHC cash_flow (annual, 2024-12-31) — Earnings Losses From Equity Investments: -6347000.00
TMHC balance_sheet (annual, 2024-12-31) — Employee Benefits: 174509000.00
TMHC cash_flow (annual, 2024-12-31) — End Cash Position: 487166000.00
TMHC cash_flow (annual, 2024-12-31) — Financing Cash Flow: -393571000.00
TMHC balance_sheet (annual, 2024-12-31) — Finished Goods: 6234084000.00
TMHC cash_flow (annual, 2024-12-31) — Free Cash Flow: 173749000.00
TMHC cash_flow (annual, 2024-12-31) — Gain Loss On Sale Of PPE: 0.00
TMHC balance_sheet (annual, 2024-12-31) — Gains Losses Not Affecting Retained Earnings: 2509000.00
TMHC income_statement (annual, 2024-12-31) — General And Administrative Expense: 314406000.00
TMHC balance_sheet (annual, 2024-12-31) — Goodwill: 663197000.00
TMHC balance_sheet (annual, 2024-12-31) — Goodwill And Other Intangible Assets: 663197000.00
TMHC balance_sheet (annual, 2024-12-31) — Gross PPE: 600434000.00
TMHC income_statement (annual, 2024-12-31) — Gross Profit: 1984212000.00
TMHC cash_flow (annual, 2024-12-31) — Income Tax Paid Supplemental Data: 264425000.00
TMHC cash_flow (quarterly, 2024-12-31) — Income Tax Paid Supplemental Data: 75702000.00
TMHC balance_sheet (annual, 2024-12-31) — Income Tax Payable: 2243000.00
TMHC balance_sheet (annual, 2024-12-31) — Interest Payable: 32288000.00
TMHC balance_sheet (annual, 2024-12-31) — Inventory: 6234084000.00
TMHC balance_sheet (annual, 2024-12-31) — Invested Capital: 7987018000.00
TMHC cash_flow (annual, 2024-12-31) — Investing Cash Flow: -136441000.00
TMHC balance_sheet (annual, 2024-12-31) — Investments And Advances: 439721000.00
TMHC balance_sheet (annual, 2024-12-31) — Investmentsin Joint Venturesat Cost: 439721000.00
TMHC balance_sheet (quarterly, 2024-12-31) — Investmentsin Joint Venturesat Cost: 439721000.00
TMHC cash_flow (annual, 2024-12-31) — Issuance Of Debt: 3752098000.00
TMHC balance_sheet (annual, 2024-12-31) — Line Of Credit: 0.00
TMHC balance_sheet (annual, 2024-12-31) — Long Term Capital Lease Obligation: 78998000.00
TMHC balance_sheet (annual, 2024-12-31) — Long Term Debt: 2120483000.00
TMHC balance_sheet (annual, 2024-12-31) — Long Term Debt And Capital Lease Obligation: 2199481000.00
TMHC cash_flow (annual, 2024-12-31) — Long Term Debt Issuance: 3652098000.00
TMHC cash_flow (annual, 2024-12-31) — Long Term Debt Payments: -3684599000.00
TMHC balance_sheet (annual, 2024-12-31) — Long Term Equity Investment: 439721000.00
TMHC balance_sheet (annual, 2024-12-31) — Long Term Provisions: 214105000.00
TMHC balance_sheet (annual, 2024-12-31) — Minority Interest: 11645000.00
TMHC income_statement (annual, 2024-12-31) — Minority Interests: -3261000.00
TMHC cash_flow (annual, 2024-12-31) — Net Business Purchase And Sale: -129809000.00
TMHC cash_flow (annual, 2024-12-31) — Net Common Stock Issuance: -347598000.00
TMHC balance_sheet (annual, 2024-12-31) — Net Debt: 1633332000.00
TMHC income_statement (annual, 2024-12-31) — Net Income: 883309000.00
TMHC income_statement (annual, 2024-12-31) — Net Income Common Stockholders: 883309000.00
TMHC income_statement (annual, 2024-12-31) — Net Income Continuous Operations: 886570000.00
TMHC income_statement (annual, 2024-12-31) — Net Income From Continuing And Discontinued Operation: 883309000.00
TMHC income_statement (annual, 2024-12-31) — Net Income From Continuing Operation Net Minority Interest: 883309000.00
TMHC cash_flow (annual, 2024-12-31) — Net Income From Continuing Operations: 886570000.00
TMHC income_statement (annual, 2024-12-31) — Net Income Including Noncontrolling Interests: 886570000.00
TMHC income_statement (annual, 2024-12-31) — Net Interest Income: -13316000.00
TMHC cash_flow (annual, 2024-12-31) — Net Investment Purchase And Sale: 0.00
TMHC cash_flow (annual, 2024-12-31) — Net Issuance Payments Of Debt: -32501000.00
TMHC cash_flow (annual, 2024-12-31) — Net Long Term Debt Issuance: -32501000.00
TMHC income_statement (annual, 2024-12-31) — Net Non Operating Interest Income Expense: -13316000.00
TMHC cash_flow (annual, 2024-12-31) — Net Other Financing Charges: -8756000.00
TMHC balance_sheet (annual, 2024-12-31) — Net PPE: 600434000.00
TMHC cash_flow (annual, 2024-12-31) — Net PPE Purchase And Sale: -36330000.00
TMHC cash_flow (annual, 2024-12-31) — Net Short Term Debt Issuance: 0.00
TMHC cash_flow (quarterly, 2024-12-31) — Net Short Term Debt Issuance: 0.00
TMHC balance_sheet (annual, 2024-12-31) — Net Tangible Assets: 5203338000.00
TMHC balance_sheet (annual, 2024-12-31) — Non Current Deferred Assets: 76248000.00
TMHC balance_sheet (annual, 2024-12-31) — Non Current Deferred Taxes Assets: 76248000.00
TMHC income_statement (annual, 2024-12-31) — Normalized EBITDA: 1254904000.00
TMHC income_statement (annual, 2024-12-31) — Normalized Income: 883309000.00
TMHC cash_flow (annual, 2024-12-31) — Operating Cash Flow: 210079000.00
TMHC cash_flow (annual, 2024-12-31) — Operating Gains Losses: -6347000.00
TMHC income_statement (annual, 2024-12-31) — Operating Income: 1213714000.00
TMHC income_statement (annual, 2024-12-31) — Operating Revenue: 8168136000.00
TMHC balance_sheet (annual, 2024-12-31) — Ordinary Shares Number: 102241978.00
TMHC balance_sheet (annual, 2024-12-31) — Other Current Assets: 329388000.00
TMHC balance_sheet (quarterly, 2024-12-31) — Other Current Assets: 329388000.00
TMHC balance_sheet (annual, 2024-12-31) — Other Equity Adjustments: 2509000.00
TMHC income_statement (annual, 2024-12-31) — Other Gand A: 314406000.00
TMHC income_statement (annual, 2024-12-31) — Other Income Expense: -44280000.00
TMHC cash_flow (annual, 2024-12-31) — Other Non Cash Items: 80176000.00
TMHC balance_sheet (annual, 2024-12-31) — Other Non Current Liabilities: 75560000.00
TMHC income_statement (annual, 2024-12-31) — Other Non Operating Income Expenses: -50627000.00
TMHC balance_sheet (annual, 2024-12-31) — Other Properties: 300766000.00
TMHC balance_sheet (annual, 2024-12-31) — Other Receivables: 217703000.00
TMHC balance_sheet (annual, 2024-12-31) — Payables: 309084000.00
TMHC balance_sheet (annual, 2024-12-31) — Payables And Accrued Expenses: 516145000.00
TMHC balance_sheet (annual, 2024-12-31) — Prepaid Assets: 41254000.00
TMHC balance_sheet (quarterly, 2024-12-31) — Prepaid Assets: 41254000.00
TMHC income_statement (annual, 2024-12-31) — Pretax Income: 1156118000.00
TMHC cash_flow (annual, 2024-12-31) — Proceeds From Stock Option Exercised: -4716000.00
TMHC cash_flow (annual, 2024-12-31) — Purchase Of Business: -129809000.00
TMHC cash_flow (annual, 2024-12-31) — Purchase Of Investment: 0.00
TMHC cash_flow (annual, 2024-12-31) — Purchase Of PPE: -36330000.00
TMHC balance_sheet (annual, 2024-12-31) — Receivables: 217703000.00
TMHC income_statement (annual, 2024-12-31) — Reconciled Cost Of Revenue: 6183924000.00
TMHC income_statement (annual, 2024-12-31) — Reconciled Depreciation: 41190000.00
TMHC cash_flow (annual, 2024-12-31) — Repayment Of Debt: -3784599000.00
TMHC cash_flow (annual, 2024-12-31) — Repurchase Of Capital Stock: -347598000.00
TMHC balance_sheet (annual, 2024-12-31) — Restricted Cash: 15000.00
TMHC balance_sheet (annual, 2024-12-31) — Retained Earnings: 4393853000.00
TMHC cash_flow (annual, 2024-12-31) — Sale Of Investment: 0.00
TMHC income_statement (annual, 2024-12-31) — Selling And Marketing Expense: 456092000.00
TMHC income_statement (annual, 2024-12-31) — Selling General And Administration: 770498000.00
TMHC balance_sheet (annual, 2024-12-31) — Share Issued: 162061709.00
TMHC cash_flow (annual, 2024-12-31) — Short Term Debt Issuance: 100000000.00
TMHC cash_flow (quarterly, 2024-12-31) — Short Term Debt Issuance: 0.00
TMHC cash_flow (annual, 2024-12-31) — Short Term Debt Payments: -100000000.00
TMHC cash_flow (quarterly, 2024-12-31) — Short Term Debt Payments: 0.00
TMHC income_statement (annual, 2024-12-31) — Special Income Charges: 0.00
TMHC income_statement (quarterly, 2024-12-31) — Special Income Charges: 0.00
TMHC cash_flow (annual, 2024-12-31) — Stock Based Compensation: 22461000.00